Zika vaccine: Inovio gets go ahead for starting human trials
by Press Release from Outbreak News Today on (#1HS9H)
Inovio Pharmaceuticals, Inc. and GeneOne Life Science, Inc. today announced that they have received approval to initiate a phase I human trial to evaluate Inovio's Zika DNA vaccine (GLS-5700) to prevent infection from this concerning virus. In preclinical testing this synthetic vaccine induced robust antibody and T cell responses in small and large animal models, ["]
